CTLA4 and neoplasm: On the other hand, their killing effect on the tumor cells at various DOX dose gradients had been likewise noticeably larger compared to those of the FC + LPS-DOX, FC + LPS-DOX+Nb36, FC + LPS-DOX+anti-CTLA-4 mAb and FC + LPS-RGD-Nb36 groups.